FDA Center for Drug Evaluation and Research Rare Diseases Public Workshop: Strategies, Tools, and Best Practices for Effective Advocacy in Rare Diseases Drug Development

Summary

The Food and Drug Administration (FDA) is hosting a public workshop to educate the rare disease community on strategies for effective advocacy in rare diseases drug development, building on previous patient advocacy efforts. The workshop aims to enhance collaboration between the FDA and the rare disease community to improve drug development programs.